Press Releases

Sensus Healthcare to Present at the H.C. Wainwright 24th Annual Global Investment Conference

BOCA RATON, Fla., Sept. 09, 2022 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference being held September 12-14, 2022. The hybrid […]

Sensus Healthcare Adds Dr. Mohammad K. Khan to Medical Advisory Board

Addition of World-Renowned Radiation Oncologist Deepens Pool of Expertise BOCA RATON, Fla., Sept. 07, 2022 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions, announces the addition of Mohammad K. Khan, M.D., Ph.D. to its Medical Advisory Board. This […]

Sensus Healthcare Launches Upgrade to its SRT-100 Vision System with New State-of-the-Art Ultrasound Capabilities

Includes a new ergonomic probe to operate in ideal MHz range to view all layers of skin BOCA RATON, Fla, Aug. 09, 2022 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions, announces an upgrade to its full-featured SRT-100 […]

Sensus Healthcare Second Quarter 2022 Financial Results Feature Revenue Growth of 124%

Diluted EPS of $0.21 compares with $(0.02) for the year-ago quarter Affirms expectations for full-year profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Aug. 04, 2022 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, […]

Sensus Healthcare Takes Order for 10 TransDermal Infusion Systems™ Supporting Hair Enhancement Centers Expansion Along with U.SK Under Skin's Hair-Health Serum

BOCA RATON, Fla., July 27, 2022 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions, announces the sale of 10 Transdermal Infusion Systems™ to Hair Enhancement Centers (HEC), a rapidly-growing chain of Texas-based hair loss treatment centers. The Systems […]

Sensus Healthcare to Host Second Quarter 2022 Financial Results and Business Update Conference Call on August 4, 2022

BOCA RATON, Fla., July 26, 2022 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, August 4, 2022 at 4:30 p.m. Eastern time to discuss the financial results for the second quarter […]

« Previous 1 2 3 4 5 6 7 8 9 10 … 19 20 21 22 23 24 25 26 27 28 Next »